Form 4: Bio-Key International Director Acquires Shares as Compensation

Director Cameron E. Williams receives 2,971 shares of Bio-Key International as payment for board meeting attendance fees.

Summary

• On March 20, 2025, Cameron E. Williams, a director of Bio-Key International, acquired 2,971 shares of common stock.
• The shares were issued under the company's 2023 Stock Incentive Plan as payment for board meeting attendance fees.
• Following the transaction, Williams directly owns 11,787 shares of Bio-Key International.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction of a director receiving shares as compensation. It doesn't indicate any significant positive or negative outlook for the company.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• The use of the 2023 Stock Incentive Plan aligns director compensation with company performance.

Industry Context

Director share acquisitions are common and can be seen as a positive sign, indicating confidence in the company's future performance. The use of stock incentive plans is a standard practice to align the interests of directors and shareholders.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with those of the shareholders.

Key Dates

Keywords

Bio-Key International, Director, Share Acquisition, Stock Incentive Plan, Cameron E. Williams, BKYI, Compensation, Board Meeting Fees